Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 6, 2012, Pages 1257-1264

  Gomez, Elodie ^a,b   Vercauteren, Magali ^a,b   Kurtz, Baptiste ^a,b   Ouvrard Pascaud, Antoine ^a,b   Mulder, Paul ^a,b   Henry, Jean Paul ^a,b   Besnier, Marie ^a,b   Waget, Aurélie ^c   Hooft Van Huijsduijnen, Rob ^d   Tremblay, Michel L ^e   Burcelin, Remy ^c   Thuillez, Christian ^a,b   Richard, Vincent ^a,b  

^a Université Normandie de Rouen   (France)

^b UNIVERSITY OF ROUEN   (France)

^c INSERM   (France)

^d MSPRI   (Switzerland)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Echocardiography; Endothelium; Heart failure; Insulin; Signal transduction; Tyrosine

Indexed keywords

AS 279; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; ELECTROCARDIOGRAPHY; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME INHIBITION; GENE DELETION; HEART FAILURE; HEART HYPERTROPHY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART OUTPUT; HYPERINSULINEMIA; IN VITRO STUDY; INSULIN SENSITIVITY; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

ANIMALS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ENZYME INHIBITORS; GENE DELETION; GENE EXPRESSION; HEART FAILURE; HEMODYNAMICS; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; NITRIC OXIDE SYNTHASE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; VENTRICULAR REMODELING;

MUS;

EID: 84860509846     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.03.003     Document Type: Article

References (24)

1. Elchebly M., Payette P., Michaliszyn E., Cromlish W., Collins S., Loy A.L., et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999, 283:1544-1548.
2. Elchebly M., Cheng A., Tremblay M.L. Modulation of insulin signaling by protein tyrosine phosphatases. J Mol Med 2000, 78:473-482.
3. Cheng A., Dube N., Gu F., Tremblay M.L. Coordinated action of protein tyrosine phosphatases in insulin signal transduction. Eur J Biochem 2002, 269:1050-1059.
4. Delibegovic M., Bence K.K., Mody N., Hong E.G., Ko H.J., Kim J.K., et al. Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B. Mol Cell Biol 2007, 27:7727-7734.
5. Dube N., Tremblay M.L. Beyond the metabolic function of PTP1B. Cell Cycle 2004, 3:550-553.
6. Vercauteren M., Remy E., Devaux C., Dautreaux B., Henry J.P., Bauer F., et al. Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure. Circulation 2006, 114:2498-2507.
7. Varin R., Mulder P., Richard V., Tamion F., Devaux C., Henry J.P., et al. Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure. Role of nitric oxide, prostanoids, and oxidant stress. Circulation 1999, 99:2951-2957.
8. Jones S.P., Greer J.J., van Haperen R., Duncker D.J., de Crom R., Lefer D.J. Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. Proc Natl Acad Sci U S A 2003, 100:4891-4896.
9. Witteles R.M., Fowler M.B. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol 2008, 51:93-102.
10. Swan J.W., Walton C., Godsland I.F., Clark A.L., Coats A.J., Oliver M.F. Insulin resistance in chronic heart failure. Eur Heart J 1994, 15:1528-1532.
11. Knauf C., Cani P.D., Ait-Belgnaoui A., Benani A., Dray C., Cabou C., et al. Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure. Endocrinology 2008, 149:4768-4777.
12. Cabou C., Campistron G., Marsollier N., Leloup C., Cruciani-Guglielmacci C., Penicaud L., et al. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity. Diabetes 2008, 57:2577-2587.
13. Kim F., Gallis B., Corson M.A. TNF-alpha inhibits flow and insulin signaling leading to NO production in aortic endothelial cells. Am J Physiol Cell Physiol 2001, 280:C1057-C1065.
14. Varin R., Mulder P., Tamion F., Richard V., Henry J.P., Lallemand F., et al. Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin. Circulation 2000, 102:351-356.
15. Greer J.J., Kakkar A.K., Elrod J.W., Watson L.J., Jones S.P., Lefer D.J. Low-dose simvastatin improves survival and ventricular function via eNOS in congestive heart failure. Am J Physiol Heart Circ Physiol 2006, 291:H2743-H2751.
16. Balakumar P., Kathuria S., Taneja G., Kalra S., Mahadevan N. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?. J Mol Cell Cardiol 2012, 52:83-89.
17. de Waard M.C., van Haperen R., Soullie T., Tempel D., de Crom R., Duncker D.J. Beneficial effects of exercise training after myocardial infarction require full eNOS expression. J Mol Cell Cardiol 2010, 48:1041-1049.
18. Belke D.D., Betuing S., Tuttle M.J., Graveleau C., Young M.E., Pham M., et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 2002, 109:629-639.
19. Hu P., Zhang D., Swenson L., Chakrabarti G., Abel E.D., Litwin S.E. Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol 2003, 285:H1261-H1269.
20. Liao R., Jain M., Cui L., D'Agostino J., Aiello F., Luptak I., et al. Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation 2002, 106:2125-2131.
21. Haj F.G., Markova B., Klaman L.D., Bohmer F.D., Neel B.G. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B. J Biol Chem 2003, 278:739-744.
22. Kasibhatla B., Wos J., Peters K.G. Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes. Curr Opin Investig Drugs 2007, 8:805-813.
23. Kannel W.B., Hjortland M., Castelli W.P. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974, 34:29-34.
24. De Groote P., Lamblin N., Mouquet F., Plichon D., McFadden E., Van Belle E., et al. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J 2004, 25:656-662.